B O O K - American College of Rheumatology
B O O K - American College of Rheumatology
B O O K - American College of Rheumatology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Gerlag, Danielle Marie, MD, PhD<br />
The Preclinical Stage <strong>of</strong> Rheumatoid Arthritis:<br />
Towards Prevention <strong>of</strong> Disease? . . . . . . . 77<br />
Disclosure: Nothing to Disclose<br />
Gib<strong>of</strong>sky, Allan, MD, JD<br />
Pain Management in the Age <strong>of</strong> Abuse and<br />
Litigation . . . . . . . . . . . . . . . . . . . 100<br />
Disclosure: Abbott, 8; Amgen, 8; BMS, 8; J&J, 1;<br />
Nicox, 5; Pfizer, 1, 8; UCB, 8; United States Food<br />
and Drug Administration, 5<br />
Gibson, Kyle, MS, PhD<br />
Putting ACR Osteoarthritis Guidelines into<br />
Practice: Clinical Applications for the Hip<br />
and Knee . . . . . . . . . . . . . . . . . . . .142<br />
Disclosure: Nothing to Disclose<br />
Giles, Jon T, MD<br />
Neuro Endocrine Immunology . . . . . . . . 91<br />
Disclosure: Nothing to Disclose<br />
Ginzler, Ellen M, MD, MPH<br />
Systemic Lupus Erythematosus: Novel<br />
Treatments. . . . . . . . . . . . . . . . . . .106<br />
Disclosure: Nothing to Disclose<br />
Gitomer, Richard S, MD, MBA<br />
Session I: The Essentials . . . . . . . . . . . 19<br />
Disclosure: Nothing to Disclose<br />
Gladman, Dafna D, MD<br />
Psoriatic Disease: Clinical Spectrum and<br />
Comprehensive Treatment Strategies . . . . 69<br />
Disclosure: Abbott, Amgen, Wyeth, BMS, 5<br />
Psoriatic Arthritis . . . . . . . . . . . . . . .130<br />
Disclosure: Abbott, Amgen, Wyeth, BMS, 5;<br />
Abbott, Pfizer, Amgen, Wyeth, 2<br />
Glennie, Martin J, PhD<br />
Session IV: Emerging Concepts in B cell Directed<br />
Therapies. . . . . . . . . . . . . . . . . . . . 23<br />
Disclosure: Nothing to Disclose<br />
Goldberg, Lynne J, MD<br />
Dermatopathology <strong>of</strong> Rheumatic Diseases . 57<br />
Disclosure: Nothing to Disclose<br />
Goldring, Mary B, PhD<br />
Molecular Mechanisms <strong>of</strong> Inflammatory<br />
Signaling in Cartilage Destruction . . . . . . 27<br />
Disclosure: Nothing to Disclose<br />
Goldring, Steven R, MD<br />
Bisphosphonates: Mechanism <strong>of</strong> Action and<br />
Optimizing Clinical Use . . . . . . . . . . . 135<br />
Disclosure: Nothing to Disclose<br />
2010 Hench Lecture: Glucocorticoids-<br />
Physiologic Regulation, Mechanisms <strong>of</strong> Action<br />
and Optimizing Therapeutic Applications . . 37<br />
Disclosure: Nothing to Disclose<br />
Gottenberg, Jacques-Eric MD, PhD<br />
Sjögren’s Syndrome . . . . . . . . . . . . . . 92<br />
Gourley, Mark F, MD<br />
Myopathy: Issues in Diagnosis and<br />
Treatment . . . . . . . . . . . . . . . . . . .105<br />
Disclosure: Nothing to Disclose<br />
Goyal, Janak R, MD<br />
Musculoskeletal Ultrasound Course for<br />
Rheumatologists - Day One. . . . . . . . . . 17<br />
Disclosure: Nothing to Disclose<br />
Musculoskeletal Ultrasound Course for<br />
Rheumatologists - Day Two. . . . . . . . . . 22<br />
Disclosure: Nothing to Disclose<br />
Musculoskeletal Ultrasonography: Basic . . 29<br />
Disclosure: Nothing to Disclose<br />
Grahame, Rodney, MD<br />
Hypermobility . . . . . . . . . . . . . . . . 108<br />
Disclosure: Nothing to Disclose<br />
Joint Hypermobility Syndrome . . . . . . . . 90<br />
Disclosure: Nothing to Disclose<br />
Genetic Disorders <strong>of</strong> Connective Tissue<br />
and Joint Hypermobility . . . . . . . . . . . 37<br />
Disclosure: Nothing to Disclose<br />
Green, Carmen R, MD<br />
Disparities and Pain: Examining Research,<br />
Practice and Policy . . . . . . . . . . . . . . 95<br />
Disclosure: Nothing to Disclose<br />
Grom, Alexei A, MD<br />
Autologous Stem Cell Transplantation in<br />
Pediatric <strong>Rheumatology</strong>: Indications and<br />
Associated Morbidity . . . . . . . . . . . . . 68<br />
Disclosure: Nothing to Disclose<br />
New Development in Systemic Juvenile<br />
Idiopathic Arthritis - From Bench to Effective<br />
Interventions . . . . . . . . . . . . . . . . .121<br />
Disclosure: Nothing to Disclose<br />
Gultekin, Sakir Humayun, MD<br />
Muscle Involvement in Rheumatic Diseases . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . .101<br />
Disclosure: Nothing to Disclose<br />
Gunawardena, Harsha, MD<br />
Inflammatory Myopathy Update. . . . . . . 77<br />
Disclosure: Nothing to Disclose<br />
H<br />
Haberman, Ann M, PhD<br />
Session II: B cell Activation and Trafficking . 22<br />
Disclosure: Nothing to Disclose<br />
Hahn, Bevra H, MD<br />
Mouse to House: Lessons Learned About Lupus<br />
Therapeutics . . . . . . . . . . . . . . . . . . 39<br />
Disclosure: Alderbio Pharm, 5; Aspreva, 2;<br />
Bristol Myers Squibbs, 9<br />
Hajj-Ali, Rula, MD<br />
Central Nervous System Vasculitis . . . . . . 28<br />
Disclosure: Nothing to Disclose<br />
Hamilton, John A, PhD, DSc<br />
Macrophage Differentiation . . . . . . . . . 55<br />
Disclosure: CSL Ltd, 5; Morphosys AG, 2, 5, 7;<br />
NovoNordisk, 5<br />
Hanly, John G, MD<br />
The Brain and Systemic Lupus Erythematosus:<br />
2010 Update . . . . . . . . . . . . . . . . . . 66<br />
Disclosure: Genentech USA, 5; GSK Canada, 5;<br />
Roche Canada, 2, 5<br />
Hannan, Marian T, DSc, MPH<br />
A Foot Orthotic Is Not Just a Foot Orthotic . .<br />
. . . . . . . . . . . . . . . . . . . . . . . . .131<br />
Disclosure: Nothing to Disclose<br />
Building Effective Teams: Recommended<br />
Leadership Strategies . . . . . . . . . . . . 100<br />
Disclosure: Nothing to Disclose<br />
You’ve Got the Power: How to Use and Teach<br />
Statistical Power for Studies and Grants. . . 47<br />
Disclosure: Nothing to Disclose<br />
Hansen, Karen E, MD<br />
Vitamin D and Bone Health. . . . . . . . . . 36<br />
Disclosure: NIH, 2<br />
Hardy, Richard R, PhD<br />
Session I: B cell Development . . . . . . . . 20<br />
Disclosure: Nothing to Disclose<br />
Harrington, J. Timothy, MD<br />
Session II: Applications to Musculoskeletal<br />
Medicine . . . . . . . . . . . . . . . . . . . . 19<br />
Disclosure: CORRONA, 5; Murray Electronics, 4;<br />
Wyeth, 8<br />
Haskard, Dorian O, DM<br />
Behçet’s Disease. . . . . . . . . . . . . . . . 88<br />
Disclosure: Nothing to Disclose<br />
Hazes, Johanna, MD, PhD<br />
Rheumatoid Arthritis: Early Rheumatoid<br />
Arthritis . . . . . . . . . . . . . . . . . . . . 36<br />
Disclosure: BMS, 8; Roche, 2; Wyeth, 2<br />
Helmick, Charles G, MD<br />
Top 10 in ‘10: Top 10 Public Health Advances<br />
in the First 10 Years <strong>of</strong> the Centers for Disease<br />
Control and Prevention Arthritis Program. .147<br />
Disclosure: Nothing to Disclose<br />
Higgs, Jay B, MD<br />
Musculoskeletal Ultrasound Course for<br />
Rheumatologists - Day One. . . . . . . . . . 17<br />
Disclosure: Nothing to Disclose<br />
Musculoskeletal Ultrasound Course for<br />
Rheumatologists - Day Two. . . . . . . . . . 22<br />
Disclosure: Nothing to Disclose<br />
Hirsch, Irl B, MD<br />
Diabetes 2010: More than Autoimmunity and<br />
Adipocytes . . . . . . . . . . . . . . . . . . . 94<br />
Disclosure: Abbott Diabetes Care, 5; Bayer, 5;<br />
Johnson & Johnson, 5; Novo Nordisk, 2; Roche, 5<br />
Ho, Nancy A, MHA<br />
Money Talks: How to Incentivize Staff . . . . 46<br />
Disclosure: Nothing to Disclose<br />
Hochberg, Marc C, MD, MPH<br />
Evidence-based Non-pharmacological Treatment<br />
for Hip, Knee, and Hand Osteoarthritis: The New<br />
ACR Guidelines . . . . . . . . . . . . . . . . 34<br />
Disclosure:, 8; Astra-Zeneca Pharmaceutical<br />
CO, 8; Bayer HealthCare LLC, 8; Bioberica SA, 8;<br />
CombinatoRx, 8; Covidien, 8; Eli Lilly Co., 8; Endo<br />
Pharmaceuticals, 8; GlaxoSmithKline, 8; Merck<br />
& Co., Inc., 8; Merck Serono International SA, 8;<br />
NicOX SA, 8; Novartis Pharma AG, 8; Pfizer Inc.,<br />
8; Pozen, Inc., 8; San<strong>of</strong>i Aventis SA, 8; Smith &<br />
Nephew, 8; Stryker Biotech, 8<br />
Osteoarthritis - What is New in Old Joints .122<br />
Disclosure:, 8; Astra-Zeneca Pharmaceutical<br />
CO, 8; Bayer HealthCare LLC, 8; Bioberica SA, 8;<br />
CombinatoRx, 8; Covidien, 8; Eli Lilly Co., 8; Endo<br />
Pharmaceuticals, 8; GlaxoSmithKline, 8; Merck<br />
& Co., Inc., 8; Merck Serono International SA, 8;<br />
NicOX SA, 8; Novartis Pharma AG, 8; Pfizer Inc.,<br />
8; Pozen, Inc., 8; San<strong>of</strong>i Aventis SA, 8; Smith &<br />
Nephew, 8; Stryker Biotech, 8<br />
H<strong>of</strong>fman, Bruce I, MD<br />
Crystallizing Your Assessment and Treatment <strong>of</strong><br />
Difficult to Treat Gout . . . . . . . . . . . . .114<br />
Disclosure: Nothing to Disclose<br />
H<strong>of</strong>fman, Gary S, MD<br />
Giant Cell Arteritis - Diagnosis and Therapy. 69<br />
Disclosure: Nothing to Disclose<br />
2010 Program Book 305<br />
INVITED SPEAKER /MODERATOR INDEX